Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Local steroids and dysphagia in anterior cervical discectomy and fusion-does the employment of rhBMP-2 make their use a necessity?

Siasios ID, Dimopoulos VG, Fountas KN.

J Spine Surg. 2016 Sep;2(3):234-236. No abstract available.

2.

Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?

Hoffmann MF, Jones CB, Sietsema DL.

Asian Spine J. 2016 Jun;10(3):457-64. doi: 10.4184/asj.2016.10.3.457. Epub 2016 Jun 16.

3.

The Utility of Allograft Mesenchymal Stem Cells for Spine Fusion: A Literature Review.

Lubelski D, Abdullah KG, Benzel EC, Mroz TE.

Global Spine J. 2012 Jun;2(2):109-14. doi: 10.1055/s-0032-1307263. Review.

4.

BMP-2 and BMP-2/7 Heterodimers Conjugated to a Fibrin/Hyaluronic Acid Hydrogel in a Large Animal Model of Mild Intervertebral Disc Degeneration.

Peeters M, Detiger SE, Karfeld-Sulzer LS, Smit TH, Yayon A, Weber FE, Helder MN.

Biores Open Access. 2015 Oct 1;4(1):398-406. doi: 10.1089/biores.2015.0025. eCollection 2015 Oct 1.

5.

Smad1/5 and Smad4 expression are important for osteoclast differentiation.

Tasca A, Stemig M, Broege A, Huang B, Davydova J, Zwijsen A, Umans L, Jensen ED, Gopalakrishnan R, Mansky KC.

J Cell Biochem. 2015 Jul;116(7):1350-60. doi: 10.1002/jcb.25092.

6.

Clinical and radiographic outcomes of extreme lateral approach to interbody fusion with β-tricalcium phosphate and hydroxyapatite composite for lumbar degenerative conditions.

Rodgers WB, Gerber EJ, Rodgers JA.

Int J Spine Surg. 2012 Dec 1;6:24-8. doi: 10.1016/j.ijsp.2011.10.001. eCollection 2012 Dec 1.

7.

The controversy surrounding bone morphogenetic proteins in the spine: a review of current research.

Hustedt JW, Blizzard DJ.

Yale J Biol Med. 2014 Dec 12;87(4):549-61. eCollection 2014 Dec 12. Review.

8.

Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?

Lubelski D, Alvin MD, Torre-Healy A, Abdullah KG, Nowacki AS, Whitmore RG, Steinmetz MP, Benzel EC, Mroz TE.

Global Spine J. 2014 Dec;4(4):245-54. doi: 10.1055/s-0034-1394123. Epub 2014 Oct 10.

9.

Trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory?

Mckie J, Qureshi S, Iatridis J, Egorova N, Cho S, Hecht A.

Global Spine J. 2014 Jun;4(2):71-6. doi: 10.1055/s-0033-1363515. Epub 2013 Dec 19.

10.

Updates in biological therapies for knee injuries: bone.

Kfuri M Jr, de Freitas RL, Batista BB, Salim R, Castiglia MT, Tavares RA, Araújo PH.

Curr Rev Musculoskelet Med. 2014 Sep;7(3):220-7. doi: 10.1007/s12178-014-9225-z.

11.

A consensus statement regarding the utilization of BMP in spine surgery.

Walker B, Koerner J, Sankarayanaryanan S, Radcliff K.

Curr Rev Musculoskelet Med. 2014 Sep;7(3):208-19. doi: 10.1007/s12178-014-9224-0.

12.

A meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft.

Zhang H, Wang F, Ding L, Zhang Z, Sun D, Feng X, An J, Zhu Y.

PLoS One. 2014 Jun 2;9(6):e97049. doi: 10.1371/journal.pone.0097049. eCollection 2014 Jun 2. Erratum in: PLoS One. 2014;9(12):e116460.

13.

Point-counter-point debate: the association between recombinant human bone morphogenetic protein utilization and complications in spine surgery.

Siemionow K, Sundberg E, Tyrakowski M, Nandyala SV, Singh K.

Curr Rev Musculoskelet Med. 2014 Sep;7(3):200-7. doi: 10.1007/s12178-014-9219-x.

14.

An association can be found between hounsfield units and success of lumbar spine fusion.

Schreiber JJ, Hughes AP, Taher F, Girardi FP.

HSS J. 2014 Feb;10(1):25-9. doi: 10.1007/s11420-013-9367-3. Epub 2013 Nov 1.

15.

Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery.

Hsu WK, Nickoli MS, Wang JC, Lieberman JR, An HS, Yoon ST, Youssef JA, Brodke DS, McCullough CM.

Global Spine J. 2012 Dec;2(4):239-48. doi: 10.1055/s-0032-1315454. Epub 2012 Oct 9. Review.

16.

The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Vukicevic S, Oppermann H, Verbanac D, Jankolija M, Popek I, Curak J, Brkljacic J, Pauk M, Erjavec I, Francetic I, Dumic-Cule I, Jelic M, Durdevic D, Vlahovic T, Novak R, Kufner V, Bordukalo Niksic T, Kozlovic M, Banic Tomisic Z, Bubic-Spoljar J, Bastalic I, Vikic-Topic S, Peric M, Pecina M, Grgurevic L.

Int Orthop. 2014 Mar;38(3):635-47. doi: 10.1007/s00264-013-2201-1. Epub 2013 Dec 19. Review.

17.

PTH promotes allograft integration in a calvarial bone defect.

Sheyn D, Cohn Yakubovich D, Kallai I, Su S, Da X, Pelled G, Tawackoli W, Cook-Weins G, Schwarz EM, Gazit D, Gazit Z.

Mol Pharm. 2013 Dec 2;10(12):4462-71. doi: 10.1021/mp400292p. Epub 2013 Nov 8.

18.

Outcomes and complication rates of different bone grafting modalities in long bone fracture nonunions: a retrospective cohort study in 182 patients.

Flierl MA, Smith WR, Mauffrey C, Irgit K, Williams AE, Ross E, Peacher G, Hak DJ, Stahel PF.

J Orthop Surg Res. 2013 Sep 9;8:33. doi: 10.1186/1749-799X-8-33.

19.

Fusion and subsidence rate of stand alone anterior lumbar interbody fusion using PEEK cage with recombinant human bone morphogenetic protein-2.

Behrbalk E, Uri O, Parks RM, Musson R, Soh RC, Boszczyk BM.

Eur Spine J. 2013 Dec;22(12):2869-75. doi: 10.1007/s00586-013-2948-5. Epub 2013 Aug 19.

20.

Allograft cellular bone matrix in extreme lateral interbody fusion: preliminary radiographic and clinical outcomes.

Tohmeh AG, Watson B, Tohmeh M, Zielinski XJ.

ScientificWorldJournal. 2012;2012:263637. doi: 10.1100/2012/263637. Epub 2012 Dec 2.

Supplemental Content

Support Center